Wei Ling Lim
Queen Mary University of London
7 Papers
184 Citations
Wei Ling Lim is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Hepatitis B virus & Vaccination. The author has an hindex of 6, co-authored 7 publications.
Chat about Author
Papers
Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation.
TL;DR: Use of famciclovir significantly reduced hepatitis due to hepatitis B virus reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation.
71
Clearance of Persistent Hepatitis B Virus Infection in Chinese Bone Marrow Transplant Recipients Whose Donors Were Anti—Hepatitis B Core— and Anti—Hepatitis B Surface Antibody—Positive
George K. K. Lau,Raymond Liang,Cheuk-Kwong Lee,Siu Tsan Yuen,Jinlin Hou,Wei Ling Lim,Roger Williams +6 more
TL;DR: Adoptive immunity clearance of hepatitis B surface antigen was favored by hepatitis B core antibody positive-donor marrow and was not related to donor pre-BMT hepatitis Bsurface antibody titer.
53
A case-controlled study on the use of HBsAg-positive donors for allogeneic hematopoietic cell transplantation.
George K. K. Lau,Albert K. W. Lie,Yok-Lam Kwong,Cheuk-Kwong Lee,Jinlin Hou,Yu-Lung Lau,Wei Ling Lim,Raymond Liang +7 more
TL;DR: It is demonstrated that a high incidence ofHBV-related hepatitis was associated with the use of HBsAg-positive marrow for transplant, and a high viral load in the donor appeared to predispose recipients to the development of HBV- related hepatitis posttransplant.
53
Mass measles immunization campaign: experience in the Hong Kong Special Administrative Region of China
TL;DR: A two-dose strategy and supplementary campaigns will maintain measles susceptibility at levels low enough to make measles elimination the authors' goal.